We are live on
!
Find out more
State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
72 hedge funds and large institutions have $105M invested in State Street SPDR S&P Pharmaceuticals ETF in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 20 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
110,050% more call options, than puts
Call options by funds: $2.2M | Put options by funds: $2K
1.93% more ownership
Funds ownership: 45.65% → 47.58% (+1.9%)
5% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 20
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
1% less funds holding
Funds holding: 73 → 72 (-1)
10% less capital invested
Capital invested by funds: $117M → $105M (-$12M)
Holders
72
Holders Change
-1
Holders Change %
-1.37%
% of All Funds
1.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
19
Reduced
20
Closed
12
Calls
$2.2M
Puts
$2K
Net Calls
+$2.2M
Net Calls Change
-$795K
Top Buyers
| 1 |
HighTower Advisors
Chicago,
Illinois
|
+$2.24M |
| 2 |
FTUS
Flow Traders U.S.
New York
|
+$875K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$810K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$641K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$569K |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$4.25M |
| 2 |
JP Morgan Chase
New York
|
-$3.61M |
| 3 |
FMP
Financial Management Professionals
Austin,
Texas
|
-$3.19M |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$2.99M |
| 5 |
BCM
Brookstone Capital Management
Wheaton,
Illinois
|
-$2.16M |